Related Experiment Video
Updated: Dec 14, 2025

10:07
In Vitro Synthesis of Modified mRNA for Induction of Protein Expression in Human Cells
Published on: November 13, 2014
25.5K
Advances in Development of mRNA-Based Therapeutics
Lei Huang1, Luyao Zhang1, Weiwei Li1
1Stemirna Therapeutics Inc, Shanghai, 201206, China.
Current Topics in Microbiology and Immunology
|July 20, 2020
Summary
Messenger RNA (mRNA) therapeutics are advancing rapidly due to improved synthesis and delivery methods. These innovations show promise in vaccines, immunotherapy, and therapies, moving mRNA treatments toward real-world use.
Area of Science:
- Biotechnology
- Molecular Biology
- Therapeutics Development
Background:
- Significant advancements in messenger RNA (mRNA) synthesis and delivery systems have accelerated therapeutic development.
- mRNA technology has demonstrated promising preclinical and clinical results across various medical fields.
Purpose of the Study:
- To provide a comprehensive overview of recent breakthroughs in mRNA-based therapeutics.
- To highlight the expanding applications and potential of mRNA technology.
Main Methods:
- Review of recent scientific literature and clinical trial data.
- Analysis of novel mRNA synthesis and delivery technologies.
- Exploration of emerging therapeutic applications.
Main Results:
- mRNA therapeutics show efficacy in cancer vaccines, tumor immunotherapy, infectious disease prevention, and protein replacement.
- Recent clinical trial successes are driving exploration into new areas like gene editing and cell programming.
- Technological improvements are making mRNA therapies more viable for clinical application.
Conclusions:
- mRNA-based therapeutics represent a rapidly evolving field with broad clinical potential.
- Continued innovation in mRNA technology is paving the way for transformative medical treatments.
- The versatility of mRNA opens new avenues for treating diseases and enhancing health.
Related Concept Videos
Microorganisms in Medicine and Therapeutics
780
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
780
Experimental RNAi
7.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
7.1K
Regulation of Expression Occurs at Multiple Steps
25.4K
Gene expression can be regulated at almost every step from gene to protein. Transcription is the step that is most commonly regulated. This involves the binding of proteins to short regulatory sequences on the DNA. This association can either promote or inhibit the transcription of a gene associated with the respective sequence.
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
25.4K
mRNA Stability and Gene Expression
3.3K
3.3K
mRNA Stability and Gene Expression
6.3K
The structure and stability of mRNA molecules regulates gene expression, as mRNAs are a key step in the pathway from gene to protein. In eukaryotes, the half-life of mRNA varies from a few minutes up to several days. mRNA stability is essential in growth and development. The absence of the proteins regulating its stability, such as tristetraprolin in mice, can cause systemic issues, including bone marrow overgrowth, inflammation, and autoimmunity.
Cis-acting Elements involved in mRNA stability
Cis-acting Elements involved in mRNA stability
6.3K
Riboswitches
9.3K
Riboswitches are non-coding mRNA domains that regulate the transcription and translation of downstream genes without the help of proteins. Riboswitches bind directly to a metabolite and can form unique stem-loop or hairpin structures in response to the amount of the metabolite present. They have two distinct regions – a metabolite-binding aptamer and an expression platform.
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
9.3K

